Fan Linghua, Li Zhenwei, Fan Zheng, Wang Yonqiang
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2016 Mar;28(3):262-6.
To investigate the effect of necrostatin-1 (Nec-1) on the expression of liver monocyte chemotactic protein-1 (MCP-1) in septic rats and its mechanism.
Forty-eight male Sprague-Dawley (SD) rats were randomly divided into sham group, model group, and Nec-1 group by randomized digital number method, with 16 rats in each group. The model of sepsis was reproduced by cecal ligation and puncture (CLP). Rats in sham group received anesthesia, and flipping the cecum followed by closure of the abdomen without ligation of the cecum. Rats in Nec-1 group were given 1 mg/kg Nec-1 [25 mg Nec-1 solution dissolved in 2.5 mL of dimethyl sulfoxide (DMSO)] through caudal vein 30 minutes before operation, while the rats in model group were given 0.1 mL/kg of DMSO only. Blood from abdominal aorta and liver tissue in each group were collected at 0 hour and 8 hours after operation. Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were determined with automatic biochemistry analyzer. The pathological changes in liver were observed under light microscope using hematoxylin-eosin (HE) staining. The serum levels of tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) were determined by enzyme linked immunosorbent assay (ELISA). The MCP-1 mRNA expression in the liver was determined by reverse transcription-polymerase chain reaction (RT-PCR).
There was no significant differences in the levels of serum ALT, AST, TNF-α, IL-6 and expressions of liver MCP-1 mRNA at 0 hour among three groups, and the liver cellular structure was normal. At 8 hours, compared with sham group, the expressions of serum ALT, AST, TNF-α, IL-6 and liver MCP-1 mRNA were significantly increased in model group and Nec-1 group [ALT (U/L): 172.35±21.88, 129.67±18.20 vs. 60.04±11.74, AST (U/L): 511.03±34.92, 363.51±25.25 vs. 254.83±31.04, TNF-α(ng/L): 603.96±24.18, 483.87±26.60 vs. 265.74±15.14, IL-6 (ng/L): 975.62±65.37, 712.09±45.47 vs. 310.42±13.88, MCP-1 mRNA (2-ΔΔCt): 7.09±0.18, 5.51±0.45 vs. 0.99±0.06, all P < 0.05]. Levels of the above parameters in Nec-1 group at 8 hours were significantly decreased compared with those of model group (all P < 0.05). Under light microscopy, it was noted that the structure of hepatic lobules was destroyed, with exacerbation of immunocyte infiltration at 8 hours in model group. At 8 hours, it was found that Nec-1 alleviated the pathological damage in Nec-1 group.
Nec-1 can protect the liver of rats with sepsis, lower the expression of serum TNF-α and serum IL-6 and liver MCP-1 mRNA, and obviously reduce the damage of inflammation.
探讨坏死因子抑制剂-1(Nec-1)对脓毒症大鼠肝脏单核细胞趋化蛋白-1(MCP-1)表达的影响及其机制。
采用随机数字表法将48只雄性Sprague-Dawley(SD)大鼠随机分为假手术组、模型组和Nec-1组,每组16只。采用盲肠结扎穿孔术(CLP)制备脓毒症模型。假手术组大鼠仅接受麻醉,翻开盲肠后关闭腹腔,不结扎盲肠。Nec-1组大鼠在手术前30分钟经尾静脉注射1 mg/kg Nec-1[25 mg Nec-1溶液溶于2.5 mL二甲基亚砜(DMSO)],模型组大鼠仅注射0.1 mL/kg DMSO。分别于术后0小时和8小时采集各组大鼠腹主动脉血和肝脏组织。用自动生化分析仪检测血清丙氨酸氨基转移酶(ALT)和天冬氨酸氨基转移酶(AST)水平。采用苏木精-伊红(HE)染色,在光学显微镜下观察肝脏病理变化。采用酶联免疫吸附测定(ELISA)法检测血清肿瘤坏死因子-α(TNF-α)和白细胞介素-6(IL-6)水平。采用逆转录-聚合酶链反应(RT-PCR)法检测肝脏中MCP-1 mRNA表达。
三组大鼠术后0小时血清ALT、AST、TNF-α、IL-6水平及肝脏MCP-1 mRNA表达差异无统计学意义,肝脏细胞结构正常。术后8小时,与假手术组比较,模型组和Nec-1组血清ALT、AST、TNF-α、IL-6水平及肝脏MCP-1 mRNA表达均显著升高[ALT(U/L):172.35±21.88,129.67±18.20比60.04±11.74,AST(U/L):511.03±34.92,363.51±25.25比254.83±31.04,TNF-α(ng/L):603.96±24.18,483.87±26.60比265.74±15.14,IL-6(ng/L):975.62±65.37,712.09±45.47比310.42±13.88,MCP-1 mRNA(2-ΔΔCt):7.09±0.18,5.51±0.45比0.99±0.06,均P<0.05]。Nec-1组术后8小时上述各指标水平均显著低于模型组(均P<0.05)。光镜下观察发现,模型组术后8小时肝小叶结构破坏,免疫细胞浸润加重。术后8小时发现,Nec-1可减轻Nec-1组的病理损伤。
Nec-1可保护脓毒症大鼠肝脏,降低血清TNF-α、血清IL-6水平及肝脏MCP-1 mRNA表达,明显减轻炎症损伤。